João Marcello de Araujo-Neto

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Hepatitis C virus (HCV) chronically infects 0.5-3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the(More)
  • 1